JOHNSON & JOHNSON
Company Snapshot
Company Overview
Johnson & Johnson focuses on researching, developing, manufacturing, and commercializing pharmaceuticals and medical devices. In 2023, it completed the separation of its consumer health division, which now operates as a standalone publicly traded entity named Kenvue, listed on the New York Stock Exchange. Following this strategic divestiture, it now operates through two core business segments: innovative medicine and MedTech. The MedTech segment caters to the tissue engineering and regeneration market. The segment offering includes a broad portfolio of products used in interventional solutions, orthopedics, surgery, and vision. It also offers a diverse range of graft products across multiple medical fields, including orthopedics and cardiology.
Financial Highlights (FY 2025)
This information is available for BCC Research members only.
JOHNSON & JOHNSON In News
Company's Business Segments
- Innovative Medicine : Immunology, Neuroscience, Infectious Diseases, Cardiovascular and Metabolism, Pulmonary Hypertension.
- MedTech : MEdTech segment inclues Surgery, Orthopaedics, Interventional Solutions, Vision
Applications/End User Industries
- Surgeons
- Orthopedic Specialists
- Ophthalmologists
- General Surgeons
- Orthopedic Surgeons
- Cardiothoracic Surgeons
- Neurosurgeons
- Pulmonary Arterial Hypertension
- Gynecologists
- Obstetricians
- Rheumatologists
- Pediatricians
- Hematologists
- Pain Management Specialists
- Immunology-Related Medications
- Biologic Therapies
- Antifungal Medications
- Cardiovascular Diseases
- Dermatologists